Select publications

Habermann TM et al. Rituximab-CHOP versus CHOP with or without maintenance rituximab
in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL): An update.
Proc ASH 2004;Abstract 127.

Hainsworth JD et al. Maximizing therapeutic benefit of rituximab: Maintenance therapy
versus re-treatment at progression in patients with indolent non-Hodgkin’s lymphoma
— A randomized phase II trial of the Minnie Pearl Cancer Research Network. J Clin Oncol
2005;23(6):1088-95. Abstract

Kostakoglu L et al. PET predicts prognosis after 1 cycle of chemotherapy in aggressive
lymphoma and Hodgkin’s disease. J Nucl Med 2002;43(8):1018-27. Abstract